Skip to main content

Design Therapeutics, Inc.

DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001807120

No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Design Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Design Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Design Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Schmid John P.Director26,965IndirectJun 11, 20261
Shapiro DavidDirector–Jun 11, 20262
Lappe Rodney WDirector133,024Jun 11, 20261
George SimeonDirector, 10% Owner6,526,476IndirectJun 11, 20261
Behanna HeatherDirector1,300Jun 11, 20261
Gover Justin D.Director–Jun 11, 20262
Shah PratikPresident, CEO and Chairperson–Jan 5, 20262
Storgard ChrisChief Medical Officer–Jan 5, 20261
Jeffries SeanChief Operating Officer–Jan 5, 20261
Burgess JulieChief Accounting Officer–Jan 5, 20261
William ArsaniDirector1,000,000IndirectAug 14, 20250
Prasad DeepaDirector20,000Jun 12, 20250
Ansari Aseem Z.10% Owner–Dec 5, 20230
Xu StellaDirector4,129,950IndirectJun 2, 20230
Siffert Joao MDPresident and CEO132,619Feb 3, 20230
SR One Capital Fund I Aggregator LP10% Owner6,526,476Dec 20, 20220
Sr One Capital Management, LLC10% Owner6,526,476Dec 20, 20220
Sr One Capital Partners I, LP10% Owner6,526,476Dec 20, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 14, 2025 (view filing)Aug 131 dayWilliam ArsaniDirectorSSale−562.6K$5.25−$2.95M−36.0%1.00M after2 lots
Dec 19, 2024 (view filing)Dec 181 dayPrasad DeepaDirectorSSale−3.81K$6.27−$23.9K−16.0%20.0K after
Aug 12, 2024 (view filing)Aug 93 daysWilliam ArsaniDirectorSSale−814.9K$4.25−$3.46M−100.0%0 after
Mar 25, 2024 (view filing)Mar 22-253 daysSchmid John P.DirectorPPurchase+27.0K$3.70+$99.8KNew position27.0K after2 lots
Mar 25, 2024 (view filing)Mar 25Same dayBehanna HeatherDirectorPPurchase+1.30K$3.74+$4.86KNew position1.30K after
Oct 2, 2023 (view filing)Sep 293 daysLappe Rodney WDirectorPPurchase+21.0K$2.35+$49.4K+18.7%133.0K after
Sep 6, 2023 (view filing)Mar 30, 2021890 daysWilliam ArsaniDirectorPPurchase+700.0K$20.00+$14.0MNew position700.0K afterAmended
Aug 30, 2023 (view filing)Aug 291 dayPrasad DeepaDirectorPPurchase+12.0K$2.31+$27.7K+101.6%23.8K after
Aug 30, 2023 (view filing)Aug 28-292 daysWilliam ArsaniDirectorPPurchase+2.23M$2.40+$5.37M+292.2%3.00M after2 lots
Dec 21, 2022 (view filing)Dec 19-202 daysSiffert Joao MDPresident and CEOPPurchase+7.45K$8.39+$62.5K+6.0%132.6K after2 lots
Dec 20, 2022 (view filing)6:37 PM ETDec 16-204 daysSR One Capital Fund I Aggregator LP and 2 others10% OwnerPPurchase+900.0K$8.42+$7.57M+16.0%6.53M after3 lots
Dec 20, 2022 (view filing)Dec 16-204 daysGeorge SimeonDirector, 10% OwnerPPurchase+900.0K$8.41+$7.57M+16.0%6.53M after3 lots
Dec 12, 2022 (view filing)Dec 93 daysLappe Rodney WDirectorPPurchase+15.0K$7.96+$119.4K+15.5%112.0K after
Mar 22, 2022 (view filing)Mar 211 dayWilliam ArsaniDirectorPPurchase+25.0K$18.99+$474.8K+0.9%2.80M after
Mar 22, 2022 (view filing)Mar 18-224 daysXu StellaDirectorSSale−590.9K$19.07−$11.3M−12.5%4.13M after4 lots
Sep 2, 2021 (view filing)Aug 312 daysWilliam ArsaniDirectorPPurchase+40.0K$15.45+$618.0K+1.5%2.77M after